Crossmark

Newly designed compounds from scaffolds of known actives as inhibitors of survivin: computational analysis from the perspective of fragment-based drug design

Crossref DOI link: https://doi.org/10.1007/s40203-021-00108-8

Published Online: 2021-07-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Elekofehinti, Olusola Olalekan

Iwaloye, Opeyemi https://orcid.org/0000-0001-6128-2900
Olawale, Femi

Chukwuemeka, Prosper Obed

Folorunso, Ibukun Mary
License Information

Text and Data Mining valid from 2021-07-28

Version of Record valid from 2021-07-28
More Information

Article History

Received: 23 April 2021

Accepted: 19 July 2021

First Online: 28 July 2021

Declarations

:

: No ethical clearance is required for the research

: Not applicable

: The authors declare no conflict of interest, financial or otherwise.

Document is current

Any future updates will be listed below